Tenon Medical, Inc.

Equities

TNON

US88066N2045

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:30:00 2024-04-26 pm EDT 5-day change 1st Jan Change
0.7516 USD +2.95% Intraday chart for Tenon Medical, Inc. +2.52% -52.43%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Benchmark Cuts Tenon Medical's Price Target to $3 From $5, Maintains Speculative Buy Rating MT
Tenon Medical, Inc. Appoints Kristine Jacques as Independent Member of the Board of Directors CI
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Ahead of Key Economic Data MT
Transcript : Tenon Medical, Inc., Q4 2023 Earnings Call, Mar 12, 2024
Tenon Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tenon Medical, Inc. announced that it has received $2.605115 million in funding CI
Tenon Medical, Inc. Announces Resignation of Frank Fischer as Member of Board of Directors, Audit Committee and Chairman of the Compensation Committee CI
Tenon Medical, Inc. announced that it has received $1.25 million in funding CI
Tenon Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : Tenon Medical, Inc., Q3 2023 Earnings Call, Nov 14, 2023
Earnings Flash (TNON) TENON MEDICAL Reports Q3 Revenue $944,000 MT
Tenon Medical Shares Rise 42% After Passing FDA Inspection DJ
Sector Update: Health Care Stocks Rise in Late Afternoon Trading MT
Sector Update: Health Care Stocks Declining Wednesday Afternoon MT
Sector Update: Health Care MT
Tenon Medical Seeks to Regain Nasdaq Compliance With 1-for-10 Reverse Stock Split MT
Certain Warrants of Tenon Medical, Inc. are subject to a Lock-Up Agreement Ending on 13-SEP-2023. CI
Certain Common Shares of Tenon Medical, Inc. are subject to a Lock-Up Agreement Ending on 13-SEP-2023. CI
Sector Update: Health Care Stocks Gaining Late Afternoon MT
Top Midday Decliners MT
Tenon Medical(R) Announces First Patients Treated with New Jib Instrument Kit for Catamaran(R) Si Joint Fusion System CI
Tenon Medical, Inc. announced that it has received $0.286835 million in funding from Lincoln Park Capital, LLC CI
Earnings Flash (TNON) TENON MEDICAL Reports Q2 Revenue $743,000, vs. Street Est of $933,000 MT
Transcript : Tenon Medical, Inc., Q2 2023 Earnings Call, Aug 08, 2023
Tenon Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Chart Tenon Medical, Inc.
More charts
Tenon Medical, Inc. is a medical device company. The Company has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. The Catamaran System is designed specially to resist vertical shear and rotation of the joint in which it was implanted, helping stabilize the joint in preparation for eventual fusion. The Company has also developed a proprietary two-dimensional (2D) placement protocol as well as a protocol for three-dimensional (3D) navigation utilizing the latest techniques in spine surgery.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.7516 USD
Average target price
4.5 USD
Spread / Average Target
+498.75%
Consensus
  1. Stock Market
  2. Equities
  3. TNON Stock
  4. News Tenon Medical, Inc.
  5. Sector Update: Health Care Stocks Declining Wednesday Afternoon